Revolutionize your Autoimmune-mediated T1D Research: HLA-A2 βH5® Cell Line
Open new avenue using a unique clinically relevant cell model. HLA-A2 EndoC-βH5® is a new human pancreatic beta cell line that has been specifically designed to recapitulate pathological Beta Cell killing and Dysfunction observed in autoimmune Type 1 Diabetes patients.
HLA-A2 EndoC-βH5® cell line offers you:
- Robustness: A stable model from early to pre-clinical stages of your drug discovery and development process
- Clinical relevance: Recapitulate the attack on HLA-A*02 positive human functional beta cells by CD8+ cytotoxic T cells
- Immediate availability: Order now and start your assay without delay
- No time wasting: A ready-to-use model; thaw and implement your assay at D+1
Comments are closed.
Due to recent more rigorous regulatory scrutiny on products containing animal-derived components, the U.S Customs now require a USDA import permit. This affects